1. Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma
- Author
-
Tobias Keck, Frank Makowiec, Ulrich F. Wellner, Ekaterina Petrova, Felix Rückert, Igor Khatkov, Bettina Rau, Uwe A. Wittel, Dirk Bausch, Jürgen Weitz, Louisa Bolm, Peter Bronsert, Hryhoriy Lapshyn, and Marius Distler
- Subjects
Adult ,Male ,Subset Analysis ,medicine.medical_specialty ,CA-19-9 Antigen ,Bilirubin ,Malignancy ,Gastroenterology ,Cholangiocarcinoma ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Text mining ,Internal medicine ,medicine ,Humans ,Stage (cooking) ,Lymph node ,Survival rate ,Aged ,Aged, 80 and over ,Hepatology ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Survival Rate ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,business ,Carbohydrate antigen ,Biomarkers - Abstract
Background Distal cholangiocarcinoma (DCC) is a rare malignancy and validated prognostic markers remain scarce. We aimed to evaluate the role of serum CA19-9 as a potential biomarker in DCC. Methods Patients operated for DCC at 6 high-volume surgical centers from 1994 to 2015 were identified from prospectively maintained databases. Patient baseline characteristics, surgical and histopathological parameters, as well as overall survival after resection were assessed for correlation with preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 (CA19-9). Preoperative CA19-9 to bilirubin ratio (CA19-9/BR) was classified as elevated (≥ 25 U/ml/mg/dl) according to the upper serum normal values of CA19-9 (37 U/ml) and bilirubin (1.5 mg/dl) giving a cut-off at ≥ 25 U/ml/mg/dl. Results In total 179 patients underwent resection for DCC during the study period. High preoperative CA19-9/BR was associated with advanced age and regional lymph node metastases. Median overall survival after resection was 27 months. Elevated preoperative serum CA19-9/bilirubin ratio (HR 1.6, p = 0.025), T3/4 stage (HR 1.8, p = 0.022), distant metastasis (HR 2.5, p = 0.007), tumor grade (HR 1.9, p = 0.001) and R status (HR 1.7, p = 0.023) were identified as independent negative prognostic factors following multivariable analysis. Conclusion Elevated preoperative bilirubin-adjusted serum CA19-9 correlates with regional lymph node metastases and constitutes a negative independent prognostic factor after resection of DCC.
- Published
- 2019
- Full Text
- View/download PDF